Skip to content

Structured exercise reduced symptom scores in adolescents with major depression

A trial meta-analysis favored exercise, although results varied and the abstract does not establish a best program or lasting recovery.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Structured exercise reduced depressive symptom scores on average in randomized trials involving adolescents with diagnosed major depression. The results varied across studies, and the abstract leaves longer-term durability uncertain. The evidence concerns a clinical population and symptom scores; it does not establish a preferred exercise schedule for teenagers generally.

Keep in mind

This abstract-based explanation cannot assess the full trial reports. Results varied substantially, and the abstract gives no confidence interval for the overall effect.

THE NUMBERS, WITH CONTEXT

What researchers found

-0.55 standard-deviation units

Depressive symptoms: standardized mean difference

Exercise versus no-exercise controls; assessment timing unreported. Negative values indicate lower symptom scores with exercise; the estimate is standardized across scales, rather than expressed in raw symptom points (p < 0.01).

CNS Neurol Disord Drug Targets, 2026 · Original source ↓

What the estimate describes

The standardized estimate summarizes differences in symptom scores across trials. It does not tell readers the share of adolescents who recovered, and the abstract does not report whether symptom changes persisted after the programs ended.

Reading the subgroup claims

Subgroup results describe several exercise formats and schedules. They do not establish a best program through direct comparisons, so the overall symptom result is more defensible than a particular intensity or session schedule.

CHECK THE ORIGINAL

The original publication

Impact of Structured Physical Exercise on Adolescent Depression: A Comprehensive Meta-Analysis of RCTs.

Sa J, Sa Filho A, Chiappa AMG et al.
CNS Neurol Disord Drug Targets · 2026

PubMed ID
41185515
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.